{
    "nctId": "NCT02536339",
    "briefTitle": "A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy",
    "officialTitle": "An Open-Label, Single-Arm, Phase II Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Central Nervous System Progression Post-Radiotherapy in Patients With HER2-Positive Metastatic Breast Cancer (PATRICIA)",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Percentage of Participants With Objective Response in the CNS, Assessed Using Response Assessment in Neuro-Oncology-Brain Metastases (RANO-BM) Criteria",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Pathologically confirmed HER2-positive MBC\n* Progression of or new brain metastases after completion of whole-brain radiotherapy or stereotactic radiosurgery\n* Completion of whole-brain radiotherapy or stereotactic radiosurgery more than 60 days prior to enrollment\n* Stable systemic disease\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\n* LVEF at least 50%\n* Adequate hematologic, renal, and hepatic function\n* Life expectancy more than 12 weeks\n\nExclusion Criteria:\n\n* Progression of systemic disease at Screening\n* Leptomeningeal disease\n* History of intolerance or hypersensitivity to study drug\n* Use of certain investigational therapies within 21 days prior to enrollment\n* Current anthracycline use\n* Unwillingness to discontinue ado-trastuzumab emtansine or lapatinib use\n* Active infection\n* Pregnant or lactating women\n* Significant history or risk of cardiac disease\n* Symptomatic intrinsic lung disease or lung involvement\n* History of other malignancy within the last 5 years",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}